- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
/-
Good afternoon, and warmly welcome to Novo Nordisk's 2021 Annual General Meeting. My name is Helge Lund, and I'm the Chair of the Board of Directors of Novo Nordisk. And due to the COVID-19 restrictions, I'm calling in from my home country, Norway.
And let me start out by wishing that you all are safe and well. We had, of course, hoped for the COVID-19 restrictions to have been a thing of the past in 2021, but we still need to be careful and to have precautionary measures in place, why this year's general meeting is fully virtual.
So a warm welcome to all, and thank you for joining us online. Please note that this broadcast is available both in English and in Danish, just choose your preferred language. Allow me to take a minute to reflect on the year that has passed. And 2020 proved to be one of the most difficult years in recent history. The devastating impact of COVID-19 on societies and economies intensified existing challenges, such as in quality and poverty. And in times of crisis,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |